Cargando…
Testing whether drugs that weaken norepinephrine signaling prevent or treat various types of cancer
Recently, I put forth the hypothesis that the signaling molecule, norepinephrine (NE), is an etiological factor in a number of types of cancer. In this brief commentary, I summarize evidence that NE plays a role in cancer and describe details involved in testing the hypothesis in humans through epid...
Autor principal: | Fitzgerald, Paul J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2943186/ https://www.ncbi.nlm.nih.gov/pubmed/20865096 |
Ejemplares similares
-
Beta blockers, norepinephrine, and cancer: an epidemiological viewpoint
por: Fitzgerald, Paul J
Publicado: (2012) -
Hypotheses of Cancer Weakening and Origin
por: CHAN, John Cheung Yuen
Publicado: (2015) -
Norepinephrine: more of a neurohormone than a vasopressor
por: Myburgh, John
Publicado: (2010) -
Arginine vasopressin in septic shock: supplement or substitute for norepinephrine?
por: Rehberg, Sebastian, et al.
Publicado: (2009) -
Arginine vasopressin versus norepinephrine: will the stronger one win the race?
por: Ertmer, Christian, et al.
Publicado: (2006)